Core Laboratories (CLB) Revenue (2022 - 2026)

Core Laboratories has reported Revenue for 5 years, with the latest figure at $121.8 million in Q1 2026.

• For the quarter ending Q1 2026, Revenue fell 1.45% year-over-year to $121.8 million; the trailing twelve-month figure through Mar 2026 stood at $524.7 million (up 1.34% YoY), and the FY2025 full-year result was $526.5 million, up 0.51% from the prior year.
• Revenue for Q1 2026 stood at $121.8 million, down from $138.3 million in the prior quarter.
• The five-year high for Revenue was $138.3 million in Q4 2025, with the low at $120.9 million in Q2 2022.
• Historically, Revenue has averaged $128.5 million across 5 years, with a median of $128.3 million in 2023.
• Annual changes were most pronounced in 2024 — Revenue gained 7.22% — and 2025, when it fell 4.67%.
• Core Laboratories' Revenue stood at $127.6 million in 2022, then rose by 0.5% to $128.2 million in 2023, then advanced by 0.8% to $129.2 million in 2024, then increased by 6.98% to $138.3 million in 2025, then fell by 11.9% to $121.8 million in 2026.
• The last three Revenue figures came in at $121.8 million (Q1 2026), $138.3 million (Q4 2025), and $134.5 million (Q3 2025), per Business Quant data.